Market Overview:
The global gentamycin sulfate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of infectious diseases, rising demand for generic drugs, and growing investments in R&D by pharmaceutical companies. Based on type, the global gentamycin sulfate market is segmented into 99% purity type, 98% purity type, 95% purity type, and others. The 99% purity type segment is expected to account for the largest share of the global gentamycin sulfate market in 2018. This can be attributed to its high quality and efficacy as compared to other types of gentamycin sulfate available in the market. Based on application, the global gentamycin sulfate market is segmented intogentamicin Sulfate eye drops,gentamicin Sulfate tablets,,gentamicin Sulfates injection,,gentamicin Sulfates granule,,and others (including ophthalmic preparations).
 Industry Outlook.svg)
Product Definition:
Gentamycin sulfate is a topical antibiotic used to treat skin infections. It works by killing the bacteria that cause the infection. Gentamycin sulfate is also used to prevent or slow the progression of bacterial endocarditis in people with heart valve disease.
99% Purity Type:
99% purity type is a high-quality gentamycin sulfate, which has passed through at least one purification process. It contains more than 99% of the drug substance. The product is used as an antibiotic and antifungal agent in pharmaceuticals and nutraceuticals industries.
98% Purity Type:
98% purity type is a high-purity form of any substance, which contains less than 2% impurities by weight. It is used in the production of various chemicals such as antibiotics and other pharmaceutical drugs. 98% purity type has applications in research laboratories for determining the toxicity levels of new compounds before their commercialization.
Application Insights:
Gentamicin sulfate is used for the treatment of various bacterial infections. The drug is an effective alternative to antibiotics such as penicillin and erythromycin which are highly toxic if not taken properly. Therefore, it has gained immense popularity among healthcare providers and patients who are allergic to penicillin or erythromycin.
The 99% purity type of gentamycin sulfate produced globally is majorly used for ophthalmic applications owing to its high safety profile and minimal side effects when compared with other drugs in the same category such as Tobramycin. Owing to its non-toxic nature, it can be administered directly into the eye without any harm. It also does not require a separate dosage form like tablets or injections; instead, it comes in the form of drops that can be inserted directly into each eye every 12 hours (as needed).
Regional Analysis:
Europe dominated the global gentamycin sulfate market in terms of revenue with a share of 33.0% in 2017. This is attributed to increasing cases of multi-drug resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). According to WHO, there were approximately 9,000 new cases reported annually for MDR and XDR respectively as per 2016 data. In addition, growing number of approvals by regulatory bodies such as EMEA and FDA coupled with high patient awareness levels regarding available treatment options are some other factors driving the Europe market over the forecast period.
Growth Factors:
- Increasing demand from hospitals and clinics for Gentamycin Sulfate as a potent antibiotic to treat various bacterial infections.
- Rising prevalence of infectious diseases that can be treated with Gentamycin Sulfate is expected to fuel the market growth over the forecast period.
- Growing number of research and development activities for new applications of Gentamycin Sulfate is anticipated to provide lucrative opportunities for market players in the near future.
- Technological advancements in manufacturing processes are likely to result in reduced production costs, which would further boost the demand for this product over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gentamycin Sulfate (CAS 1405-41-0) Market Research Report
By Type
99% Purity Type, 98% Purity Type, 95% purity Type, Others
By Application
Gentamicin Sulfate Eye Drops, Gentamicin Sulfate Tablets, Gentamicin Sulfate Injection, Gentamicin Sulfate Granule, Gentamicin Sulfate Sustained-Release Tablets
By Companies
Widely Chemical, Tuochukangyuan Pharm., Creating Chemical, MACKLIN, ACMEC, RHAWN, Yuanye Biology, Meryer, Chembest, Pure Chemistry Scientific, LGM Pharma, BOC Science, HBCChem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Gentamycin Sulfate (CAS 1405-41-0) Market Report Segments:
The global Gentamycin Sulfate (CAS 1405-41-0) market is segmented on the basis of:
Types
99% Purity Type, 98% Purity Type, 95% purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gentamicin Sulfate Eye Drops, Gentamicin Sulfate Tablets, Gentamicin Sulfate Injection, Gentamicin Sulfate Granule, Gentamicin Sulfate Sustained-Release Tablets
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Widely Chemical
- Tuochukangyuan Pharm.
- Creating Chemical
- MACKLIN
- ACMEC
- RHAWN
- Yuanye Biology
- Meryer
- Chembest
- Pure Chemistry Scientific
- LGM Pharma
- BOC Science
- HBCChem
 Market Overview.svg)
Highlights of The Gentamycin Sulfate (CAS 1405-41-0) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% Purity Type
- 98% Purity Type
- 95% purity Type
- Others
- By Application:
- Gentamicin Sulfate Eye Drops
- Gentamicin Sulfate Tablets
- Gentamicin Sulfate Injection
- Gentamicin Sulfate Granule
- Gentamicin Sulfate Sustained-Release Tablets
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gentamycin Sulfate (CAS 1405-41-0) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gentamycin sulfate is a white to off-white crystalline powder with a slightly bitter taste. It is used as an antibiotic and antiprotozoal agent.
Some of the major companies in the gentamycin sulfate (cas 1405-41-0) market are Widely Chemical, Tuochukangyuan Pharm., Creating Chemical, MACKLIN, ACMEC, RHAWN, Yuanye Biology, Meryer, Chembest, Pure Chemistry Scientific, LGM Pharma, BOC Science, HBCChem.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gentamycin Sulfate (CAS 1405-41-0) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Gentamycin Sulfate (CAS 1405-41-0) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Gentamycin Sulfate (CAS 1405-41-0) Market - Supply Chain
4.5. Global Gentamycin Sulfate (CAS 1405-41-0) Market Forecast
4.5.1. Gentamycin Sulfate (CAS 1405-41-0) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Gentamycin Sulfate (CAS 1405-41-0) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Gentamycin Sulfate (CAS 1405-41-0) Market Absolute $ Opportunity
5. Global Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Type
5.3.1. 99% Purity Type
5.3.2. 98% Purity Type
5.3.3. 95% purity Type
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Application
6.3.1. Gentamicin Sulfate Eye Drops
6.3.2. Gentamicin Sulfate Tablets
6.3.3. Gentamicin Sulfate Injection
6.3.4. Gentamicin Sulfate Granule
6.3.5. Gentamicin Sulfate Sustained-Release Tablets
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Gentamycin Sulfate (CAS 1405-41-0) Demand Share Forecast, 2019-2026
9. North America Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Application
9.4.1. Gentamicin Sulfate Eye Drops
9.4.2. Gentamicin Sulfate Tablets
9.4.3. Gentamicin Sulfate Injection
9.4.4. Gentamicin Sulfate Granule
9.4.5. Gentamicin Sulfate Sustained-Release Tablets
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Type
9.7.1. 99% Purity Type
9.7.2. 98% Purity Type
9.7.3. 95% purity Type
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Gentamycin Sulfate (CAS 1405-41-0) Demand Share Forecast, 2019-2026
10. Latin America Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Application
10.4.1. Gentamicin Sulfate Eye Drops
10.4.2. Gentamicin Sulfate Tablets
10.4.3. Gentamicin Sulfate Injection
10.4.4. Gentamicin Sulfate Granule
10.4.5. Gentamicin Sulfate Sustained-Release Tablets
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Type
10.7.1. 99% Purity Type
10.7.2. 98% Purity Type
10.7.3. 95% purity Type
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Gentamycin Sulfate (CAS 1405-41-0) Demand Share Forecast, 2019-2026
11. Europe Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Application
11.4.1. Gentamicin Sulfate Eye Drops
11.4.2. Gentamicin Sulfate Tablets
11.4.3. Gentamicin Sulfate Injection
11.4.4. Gentamicin Sulfate Granule
11.4.5. Gentamicin Sulfate Sustained-Release Tablets
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Applicatin
11.7. Europe Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Type
11.7.1. 99% Purity Type
11.7.2. 98% Purity Type
11.7.3. 95% purity Type
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Gentamycin Sulfate (CAS 1405-41-0) Demand Share, 2019-2026
12. Asia Pacific Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Application
12.4.1. Gentamicin Sulfate Eye Drops
12.4.2. Gentamicin Sulfate Tablets
12.4.3. Gentamicin Sulfate Injection
12.4.4. Gentamicin Sulfate Granule
12.4.5. Gentamicin Sulfate Sustained-Release Tablets
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Type
12.7.1. 99% Purity Type
12.7.2. 98% Purity Type
12.7.3. 95% purity Type
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Gentamycin Sulfate (CAS 1405-41-0) Demand Share, 2019-2026
13. Middle East & Africa Gentamycin Sulfate (CAS 1405-41-0) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Application
13.4.1. Gentamicin Sulfate Eye Drops
13.4.2. Gentamicin Sulfate Tablets
13.4.3. Gentamicin Sulfate Injection
13.4.4. Gentamicin Sulfate Granule
13.4.5. Gentamicin Sulfate Sustained-Release Tablets
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Gentamycin Sulfate (CAS 1405-41-0) Market Size and Volume Forecast by Type
13.7.1. 99% Purity Type
13.7.2. 98% Purity Type
13.7.3. 95% purity Type
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Gentamycin Sulfate (CAS 1405-41-0) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Gentamycin Sulfate (CAS 1405-41-0) Market: Market Share Analysis
14.2. Gentamycin Sulfate (CAS 1405-41-0) Distributors and Customers
14.3. Gentamycin Sulfate (CAS 1405-41-0) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Widely Chemical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Tuochukangyuan Pharm.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Creating Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MACKLIN
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ACMEC
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. RHAWN
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Yuanye Biology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Meryer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Chembest
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pure Chemistry Scientific
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. LGM Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BOC Science
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. HBCChem
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
